Abzena provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products, a growing area that requires specialist knowledge and expertise.
Abzena has a global customer base which includes the majority of the top 20 biopharmaceutical companies as well as large and small biotech companies and academic groups.
In 2015 Abzena completed two acquisitions in the USA which have given it a footprint on both the East and West coasts of the USA and a broader offering for its customers: PacificGMP, a contract biopharmaceutical manufacturing and development company, and The Chemistry Research Solution (TCRS), a contract chemistry and bioconjugation business.
Abzena has also noted continuing success in its its ABZENA Inside programmes, where therapeutic candidates using the company’s technologies are carried forward by pharmaceutrical partners. At the time of Abzena’s last reporting, eleven of such candidate drugs we in clinical stages of development.